AIM ImmunoTech Inc. (AIM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AIM ImmunoTech Inc.

    AMEX: AIM · Real-Time Price · USD
    2.61
    -0.04 (-1.51%)
    At close: Oct 03, 2025, 3:59 PM
    2.73
    4.48%
    After-hours: Oct 03, 2025, 07:34 PM EDT

    AIM ImmunoTech Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 170K 202K 141K 135K
    Cost of Revenue
    		 31K 42K 19.92M 850K
    Gross Profit
    		 139K 160K -19.78M -715K
    Operating Income
    		 -19.77M -31.92M -19.92M -18.84M
    Interest Income
    		 5.19M n/a 629K n/a
    Pretax Income
    		 -17.32M -28.96M -19.45M -19.13M
    Net Income
    		 -17.32M -28.96M -21.09M -21.51M
    Selling & General & Admin
    		 13.71M 21.14M 13.07M 8.67M
    Research & Development
    		 6.2M 10.93M 6.99M 7.67M
    Other Expenses
    		 n/a n/a 1.49M n/a
    Operating Expenses
    		 19.91M 32.08M 20.06M 16.34M
    Interest Expense
    		 585K n/a n/a 67K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 19.94M 32.12M 20.06M 17.19M
    Income Tax Expense
    		 n/a n/a 1.64M 2.39M
    Shares Outstanding (Basic)
    		 56.02M 48.59M 48.05M 47.34M
    Shares Outstanding (Diluted)
    		 56.02M 48.59M 48.05M 47.34M
    EPS (Basic)
    		 -0.31 -0.6 -0.44 -0.45
    EPS (Diluted)
    		 -0.31 -0.6 -0.44 -0.45
    EBITDA
    		 -16.49M -31.68M -19.87M -18.25M
    EBIT
    		 -16.73M -28.96M -19.92M -19.06M
    Depreciation & Amortization
    		 246K 238K -424K 805K

    Add to Watchlist